Witte, S.S.WitteAnadere, I.I.AnadereWalitza, E.E.Walitza2022-03-032022-03-031992https://publica.fraunhofer.de/handle/publica/182174STUDY DESIGN: Open prospective study. Patients: 20 outpatients with a long history of elevated fibrinogen levels and plasma viscosity, and a variety of underlying diseases. INTERVENTION: Treatment with the special ginkgo biloba extract (EGb 761), 240 mg tablets a day for a period of 12 weeks. RESULTS: The clinical diagnoses included coronary heart disease, hypertension, hypercholesterolemia and diabetes mellitus. A significant improvement in the fibrinogen levels and hemorrheological properties was seen. The medication can thus positively influence these cardiovascular risk factors over the long term.debloodblood viscositycardiovascular diseasedrug effectfibrinogenmetabolismmiddle ageplant extractprospective studyrheologyrisk factortherapeutic usetherapy610620660journal article